<DOC>
	<DOCNO>NCT01298232</DOCNO>
	<brief_summary>Left ventricular systolic time interval , include pre-ejection period ( PEP ) , ejection time ( ET ) , ratio ( PEP/ET ) , determine systolic diastolic function ventriculo-arterial coupling . The investigator show usefulness electromechanical activation time ( EMAT , equal PEP minus isovolumic contraction time ) prediction cardiac mortality re-hospitalization heart failure patient acute heart failure syndrome ( AHFS ) . Therefore , objective present proposal compare 12-month outcome EMAT-guided vs symptom-guided heart failure therapy patient AHFS .</brief_summary>
	<brief_title>One-year Outcomes Electromechanical Activation Time ( EMAT ) -Guided vs. Symptom-guided Heart Failure Therapy Acute Heart Failure Syndrome ( AHFS ) Patients</brief_title>
	<detailed_description>Left ventricular systolic time interval , include pre-ejection period ( PEP ) , ejection time ( ET ) , ratio ( PEP/ET ) , determine systolic diastolic function ventriculo-arterial coupling . The investigator show usefulness electromechanical activation time ( EMAT , equal PEP minus isovolumic contraction time ) prediction cardiac mortality re-hospitalization heart failure patient acute heart failure syndrome ( AHFS ) . Therefore , objective present proposal compare 12-month outcome EMAT-guided vs symptom-guided heart failure therapy patient AHFS . A total 120 patient age 18 year old hospitalize Taipei Veterans General Hospital National Taiwan University Hospital due AHFS enrol three year , randomize 2 treatment strategy , , intensify ( EMAT-guided ) therapy standard ( symptom-guided ) therapy . Systolic time interval EMAT normalize cardiac cycle length ( % ) measure separately separate automate acoustic device . All parameter assess within 24 hour discharge , 2 week , 3 , 6 , 12 month discharge . Patients randomize EMAT-guided group undergo intensify therapy heart failure goal reduce % EMAT &lt; 15 symptom NYHA ≤II . Patients randomize symptom-guided group standard medical care , goal reduce symptom NYHA ≤II . The primary efficacy variable defined time cardiovascular death heart failure hospitalization within 1 year randomization . This study first prospective randomize control trial study management patient AHFS use EMAT provide unique information compare two treatment strategy irrespective natriuretic peptide regard prognosis .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Patients hospitalize due AHFS plasma NTproBNP ≥ 1600 pg/ml admission . 2 . Patients give write consent participate study . 1 . Patients implanted pacemaker . 2 . Patients chronic kidney disease , stage 5 warranted dialysis . 3 . Patients hypertrophic obstructive cardiomyopathy . 4 . Patients cardiac temponade constrictive pericarditis . 5 . Acute coronary syndrome , stroke , transient ischemic attack , cardiac , carotid major vascular surgery , percutaneous coronary intervention ( PCI ) carotid angioplasty , within past 1 month prior index hospitalization . 6 . Coronary carotid artery disease likely require surgical percutaneous intervention within 6 month discharge index hospitalization . 7 . Patients leave ventricular assistance device ( LVAD device ) . 8 . Documented ventricular arrhythmia syncope episode within past 3 month , prior index hospitalization untreated . 9 . Symptomatic bradycardia second third degree heart block without pacemaker . 10 . Implantation CRT ( cardiac resynchronization therapy ) device within prior 1 month index hospitalization intent implant CRT device . 11 . Presence hemodynamically significant mitral and/or aortic valve disease , except mitral regurgitation secondary leave ventricular dilatation . 12 . Presence hemodynamically significant obstructive lesion leave ventricular outflow tract , include aortic subaortic stenosis . 13 . Severe primary pulmonary , renal hepatic disease . 14 . Presence disease life expectancy &lt; 1 year . 15 . Subjects get pregnant pregnant within 1 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>